Khalil, A; Jones, CE; Ville, Y
(2017)
Congenital Cytomegalovirus Infection: Management Update.
Current Opinion in Infectious Diseases, 30 (3).
pp. 274-280.
ISSN 1473-6527
https://doi.org/10.1097/QCO.0000000000000368
SGUL Authors: Jones, Christine Elizabeth Khalil, Asma
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (981kB) | Preview |
Abstract
Purpose of review Until recently, management options in congenital cytomegalovirus (cCMV) infection have been either conservative or termination of pregnancy. However, medical therapies aimed at reducing the risk of infection and/or its severity have recently been investigated. Recent findings In a phase 2 open label, nonrandomized trial, valaciclovir (ValACV) was given to women carrying a CMV-infected fetus. ValACV was associated with a greater proportion of asymptomatic neonates when compared with a historical cohort (82 vs. 43%). However, the study design and the small number of treated women limit its applicability. Even though initial observational data suggested that hyperimmune globulin (HIG) therapy in pregnancy was associated with a significantly lower risk of cCMV, its efficacy has not been borne out in a subsequent phase 2 randomized, placebo controlled, double-blind study [cCMV 30% in the HIG group, 44% in the placebo group ( P=0.13)]. Furthermore, 11% of fetuses in the HIG group had transient or permanent abnormalities, compared with 16% in the placebo group. Summary ValACV might have a promising role in the antenatal treatment of cCMV infection, but definitive recommendations require further research. The use of HIG should currently be limited to the research setting. Video abstract http://links.lww.com/COID/A18.
Item Type: | Article | ||||||
---|---|---|---|---|---|---|---|
Additional Information: | This is a non-final version of an article published in final form in Khalil, A; Jones, CE; Ville, Y (2017) Congenital Cytomegalovirus Infection: Management Update. Current Opinion in Infectious Diseases, 30 (3). pp. 274-280. | ||||||
Keywords: | 1103 Clinical Sciences, 1108 Medical Microbiology, 0605 Microbiology | ||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
||||||
Journal or Publication Title: | Current Opinion in Infectious Diseases | ||||||
ISSN: | 1473-6527 | ||||||
Publisher License: | Publisher's own licence | ||||||
Projects: |
|
||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/108731 | ||||||
Publisher's version: | https://doi.org/10.1097/QCO.0000000000000368 |
Statistics
Actions (login required)
![]() |
Edit Item |